Quan Vu has more than 15 years of finance, strategy and corporate development experience in the healthcare space. Prior to Opiant, he was a Staff Vice President/Chief of Staff at Anthem, responsible for strategy, planning and administration of a $2 billion budget. Before that, he was a Director in the Strategy, Corporate Development & Finance team at Impax Laboratories, focusing primarily on product licensings and acquisitions in the brand CNS space as well as capital raises and tax inversion strategies. Prior to Impax, he was part of the Strategy & Corporate Development team at Amgen, working on various biotechnology strategies, divestitures, licensings, joint ventures, collaborations and acquisitions. Earlier in his career, he spent a number of years in finance, executing multi-billion dollar transactions in the Healthcare Corporate Finance and Mergers & Acquisitions group at bulge bracket investment banks, including Morgan Stanley and Goldman Sachs. Mr. Vu holds a BA in Economics from UCLA, graduating with College, Departmental and Latin Honors (summa cum laude). He is also a Certified Treasury Professional (inactive).